HugoScore hugoscore.org

Full review

RTHM CAIHL draft report

Evidence-linked HugoScore draft report for a health AI tool that affects patients.

Agency checklist · October 30, 2026

Mixed 6 of 12 yes

Document-based draft. Independent confirmation is incomplete. Hugo has not personally verified this service.

Assessed function: RTHM intelligence platform (AI assistant 'Ana', record analysis, optional HIE record retrieval); RTHM Clinic telehealth and prescribing assessed only where it touches the AI platform

A no can mean missing documentation or institution-dependent control; it does not by itself establish harmful behavior. These categories are not clinical safety or product-quality ratings.

  • Public documents do not establish actual product behavior.
  • The independent review screened rules and selected evidence; it did not replicate all twelve answers for this tool.
See all twelve answers and their evidence
QuestionAnswerEvidence / reviewSource and reasoning
1. Told it is AIYesdocumented
Not independently replicated
are generated by artificial intelligence (AI) systems Source

Beta Program and AI Disclosure; Terms section 6 also names the AI navigation assistant 'Ana'.

2. Operator and model maker namedNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

RTHM, Inc. is named. The Sick Times quotes a co-founder saying the platform is built on 'general AI models', with no maker named on RTHM pages.

3. Patient chooses to use itYesdocumented
Not independently replicated
Signing up and interacting with the RTHM intelligence platform is free. Source

Patient signs up. Support: 'When you decide to level up your care by ordering a medication or lab via RTHM or joining the RTHM Clinic, you will be prompted to pay'.

4. Patient sets the taskNodocumented
Not independently replicated
gathers information about you through a chat feature to provide personalized guidance about the medications available through RTHM Source

Terms section 6. The AI is documented as steering toward RTHM's own medications and clinic.

5. Patient can decline or stopYesdocumented
Not independently replicated
Signing up and interacting with the RTHM intelligence platform is free. Source

Self-started rule applied (cites question 3 source). The Sick Times: RTHM's telehealth service 'is separate from its intelligence platform'. Whether prescribing intake requires using Ana is not documented.

6. Patient sees the AI outputYesdocumented
Not independently replicated
You can view your chat history in your account and delete specific conversations if desired. Source

Support FAQ. Suspected diagnoses are also listed in the account.

7. Patient can correct or challengeYesdocumented
Not independently replicated
These are listed for your review; you can manually confirm them if they are established diagnoses or dismiss them if they are inaccurate. Source

Applies to suspected diagnoses flagged by analysis. A route to contest chat answers is not documented.

8. Patient can get a copyNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

Support says clinic patients can 'download your clinical data' (clinic scope). No export of platform AI output or uploaded records is documented.

9. Patient can deleteYesdocumented
Not independently replicated
This will remove your profile and personal data from our systems Source

Support: Delete Account in Profile settings; 'some clinical assessment records must be retained for legal compliance'.

10. Training or sale does not override patient choiceNodocumented
Not independently replicated
may be used by RTHM or Medical Group to train, develop, enhance, evolve and improve the Service and the underlying AI models Source

Terms (User Information license). Privacy says Google Health wearable data is not used to train generalized models, but no general opt-out. Support says data is used to 'improve the service'.

11. Patient can run it or take it elsewhereNonot-documented
Not independently replicated
Quotation not recorded; evidence repair pending. Source

Vendor-hosted only.

12. No advertising or data businessNodocumented
Not independently replicated
may disclose, aggregate, sell, or otherwise use such de-identified information to third parties for analytics, research, or other purposes Source

Terms also allow use 'for marketing and promotional purposes'. Privacy: Google Ads remarketing and advertising-network targeting. Support says 'We do not sell your data to third parties', which conflicts with Terms on de-identified data; answered by binding Terms.

Initial coding: Claude Sonnet helpers, compiled by Claude Opus 5.5 (Anthropic). Selective review and corrections: GPT-6 Astra (OpenAI). Editor: Hugo Campos. Acceptance of corrections is not product verification.

Checklist rules · Independent review and limitations · Later evidence follow-up

Earlier report

RTHM: CAIHL reassessment

September 8, 2026. Published AI-assisted draft.

RTHM documents controls to dismiss suspected diagnoses and delete conversations. These provide practical ways to redirect the service, with deletion exceptions and model-use conditions still relevant. Clinical interpretation and underlying record correction remain separate questions.

Scope and agency posture

Patient complex-illness intelligence platform, with optional record exchange and separate paid clinical services.

Posture: Potentially agency-expanding, with vendor-funnel and data-use caveats.

Axis: 70/100, retained provisionally. No numerical recalibration was performed.

Sources and documented findings

  • The current FAQ documents confirming or dismissing suspected diagnoses, deleting individual conversations, care-team sharing and a manual-upload alternative to reciprocal HIE sharing. It also notes legally retained clinical assessments after account deletion. https://www.rthm.com/support
  • Terms permit deidentification, downstream use or sale of deidentified information, and broad user-information use for model improvement. These permissions must be read beside FAQ assurances, not treated as proof of actual sale. https://www.rthm.com/legal/terms-of-use

Patient authority

Inference from the documented workflow: The ability to dismiss a suspected diagnosis is substantive control over the platform's representation of the patient. Optional HIE participation and care-team sharing provide further choices.

Critical capacity

Editorial assessment: Organizing history and preparing questions can strengthen patient action. Profile correction is now documented, although source-linked review of every roadmap recommendation remains unverified.

Informed control

Editorial assessment: The FAQ explains reciprocal HIE exchange and its alternative. Training and derivative-use permissions remain material conditions despite simplified no-sale wording.

Assessment and limits

Update the baseline's broad correction unknown to recognize real documented controls. The paid care pathway is a potential incentive, not proof that recommendations force vendor care.

Confidence: Moderate for published controls and terms.

Remaining uncertainty: Practical roadmap editing, source provenance, consent clarity and paid-care recommendation influence remain unverified

Published documentation is evidence of stated conditions, not proof of actual implementation. Unknowns did not receive automatic negative points. Funding, sponsorship, and public code do not determine agency by themselves.

Review provenance

  • Reviewer/model: OpenAI Codex / GPT-6.
  • Method: Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
  • Human review: Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
  • Earlier review: 2026-06-20. Historical assessment. Earlier claims are not automatically reverified by this publication.